Table 3 Compliance of antiemetic treatment
Emetogenisity | Actual measure (Early) | Actual measure (Delayed) | n | Compliance |
|---|---|---|---|---|
Minimal | 5-HT3RA + DEX | no | 2 | Sufficient |
5-HT3RA | no | 1 | Sufficient | |
DEX | no | 1 | Sufficient | |
no | no | 3 | Sufficient | |
Low | 5-HT3RA + DEX | no | 29 | Sufficient |
5-HT3RA + DEX | DEX | 3 | Sufficient | |
5-HT3RA + DEX | D2RA | 1 | Sufficient | |
DEX | DEX | 1 | Sufficient | |
DEX | no | 3 | Sufficient | |
no | no | 1 | Insufficient | |
Moderate | 5-HT3RA + DEX | DEX | 6 | Sufficient |
5-HT3RA + DEX | NK1RA + DEX | 3 | Sufficient | |
NK1RA + 5-HT3RA + DEX | NK1RA | 2 | Sufficient | |
NK1RA + 5-HT3RA + steroid (MM) | NK1RA | 1 | Sufficient | |
NK1RA + 5-HT3RA + DEX | 5-HT3RA + DEX + NK1RA | 1 | Sufficient | |
5-HT3RA + DEX | no | 3 | Insufficient | |
5-HT3RA + DEX | DEX + D2RA | 1 | Sufficient | |
High | NK1RA + 5-HT3RA + DEX | NK1RA | 2 | Insufficient |
NK1RA + 5-HT3RA + steroid (ML) | NK1RA | 2 | Sufficient | |
NK1RA + 5-HT3RA + steroid (ML) | NK1RA + D2RA | 1 | Sufficient | |
5-HT3RA + DEX | DEX | 2 | Insufficient | |
5-HT3RA + DEX | no | 1 | Insufficient |